ÂÜÀòÂÒÂ×

Leo is a Next-Generation Sequencing scientist responsible for generating and sequencing DNA libraries and improving platform capabilities at LabGenius.

After completing an MSc in cancer research at UCL, he worked, mainly in industry, developing recombinant antibody fragments for cancer and COVID-19 therapies, as stand-alone molecules and as modules of engineered cell therapies. Over the past few years, Leo focussed on the development of high-throughput NGS-based antibody discovery platforms, reducing molecule delivery times by 80%.